Use of duloxetine hydrochloride drug in the preparation of a pharmaceutical composition for the treatment of cancer
- 专利权人:
- 朗齊生物医学股▲分▼有限公司
- 发明人:
- 陳丘泓,莊秀美,魏宗▲徳▼,蕭乃文
- 申请号：
- JP2017522418
- 公开号：
- JP6539345B2
- 申请日:
- 2015.10.23
- 申请国别(地区):
- JP
- 年份:
- 2019
- 代理人:
- 摘要：
- The present invention provides a new clinical indication of Cinacalcet HCl. Cinacalcet HCl is already approved by FDA. The present invention provides a Cinacalcet HCl pharmaceutical composition for treating a variety of cancer cells effectively.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- СПОСОБ ПРОГНОЗИРОВАНИЯ РОДОВ ЧЕРЕЗ ЕСТЕСТВЕННЫЕ РОДОВЫЕ ПУТИ У БЕРЕМЕННЫХ С РУБЦОМ НА МАТКЕ ПОСЛЕ ОДНОГО КЕСАРЕВА СЕЧЕНИЯ
- APPARATUS FOR INDICATING INSERTION OF MEDICINE, MEDICINE INSERTION APPARATUS, AUTO-PACKAGING APPARATUS HAVING THE SAME AND MEDICINE INSERTION AREA INDICATION METHOD THEREOF
- Appareil permettant d'indiquer l'insertion des médicaments, appareil d'insertion de médicaments, appareil de conditionnement automatique en disposant et son procédé d'indication de zone d'insertion de médicaments
- 17 - (- 1'-Propenyl) -17-3'-oxidoestra-4-en-3-one derivative, its use and the medicine containing the derivative
- NEW INDICATIONS FOR USE IN TREATING ANTIBODIES AGAINST IL-1-BETA
